impact factor, citescore
logo
 

Letters to the Editor

 

Early introduction of mepolizumab for refractory coronary vasospasm and severe acute coronary syndrome secondary to eosinophilic granulomatosis with polyangiitis: a case report


1, 2, 3, 4, 5, 6, 7

 

  1. UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy. paola.tomietto@asugi.sanita.fvg.it
  2. Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Trieste, Italy.
  3. UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
  4. UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
  5. UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy.
  6. UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste; and Department of Medical Surgical and Health Sciences, University of Trieste, Cattinara Teaching Hospital, Trieste, Italy.
  7. Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Trieste, Italy.

CER18613
2026 Vol.44, N°4
PI 0857, PF 0858
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 42018351 [PubMed]

Received: 09/02/2025
Accepted : 05/05/2025
In Press: 22/04/2026
Published: 22/04/2026

Rheumatology Article